02376nam a2200373 i 4500001001300000003000300013005001700016007001400033008004100047040003000088042000800118043001200126050001900138074001600157086002000173110006800193245034200261264007100603300002200674336002600696337002700722338003100749490007700780500002400857500003600881500002100917500002500938533010600963610005801069655003401127776039201161776039101553810005801944ocn968156987BD20171118222118.0he bmb024bbca170111s2016    dcu     b    f000 0 eng c  aPUCPRbengerdacGPOdMvI  apcc  an-us---14aKF32b.R8 2016  a1008-D (MF)0 aY 1.1/8:114-6381 aUnited States.bCongress.bHouse.bCommittee on Rules,eauthor.10aProviding for consideration of the bill (H.R. 1270) to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements :breport (to accompany H. Res. 793). 1a[Washington, D.C.] :b[U.S. Government Publishing Office],c[2016]  a2 pages ;c24 cm.  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier1 aReport / 114th Congress, 2d session, House of Representatives ;v114-638  aTitle from caption.  aShipping list no.: 2016-0269-M.  a"June 21, 2016."  aCRDP Program record.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2016]e1 microfiche : negative.10aUnited States.bCongress.bHousexRules and practice. 7aLegislative materials.2lcgft08iOnline version:aUnited States. Congress. House. Committee on Rules.tProviding for consideration of the bill (H.R. 1270) to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangementsw(OCoLC)95205405508iPrint version:aUnited States. Congress. House. Committee on Rules.tProviding for consideration of the bill (H.R. 1270) to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangementsw(OCoLC)9525908991 aUnited States.bCongress.bHouse.tReport ;v114-638.